Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality.
Nicolas GendronMarie-Agnès Dragon-DureyRichard ChocronLuc DarnigeGeorges JourdiAurélien PhilippeCamille Chenevier-GobeauxJérôme HadjadjJérôme DucheminLina KhiderNader YatimGuillaume GoudotDaphné KrzischBenjamin DebucLaetitia MaugeFrançoise LevavasseurFrédéric PeneJeremy BoussierElise SourdeauJulie BrichetNadège OchatClaire GoulvestreChristophe PeroninoTali-Anne SzwebelFranck PagesPascale GaussemCharles-Marc SamamaCherifa CheurfaBenjamin PlanquetteOlivier SanchezJean-Luc DiehlTristan MiraultMichaela FontenayBenjamin TerrierDavid M SmadjaPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
Patients with COVID-19 have an increased prevalence of LAC positivity associated with biologic markers of inflammation. However, LAC positivity at the time of hospital admission is not associated with VTE risk and/or in-hospital mortality.